SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Andrew H who wrote (21278)5/21/1998 1:11:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
Actually I was at Fox Chapel's Kennywood Day and missed most of today's action. Looks like volume was good and price slipped a bit. AP did a highlight of ASCO which had five findings (none LGND). Included were Herceptin, SERMs (Evista and Tamoxifen), and 13-cis retinoic acid (isotretinoin) treatment of brain tumors.

That may be a new indication for LGD1550.